%20(1).svg)
.png)
CEO Dan Smithey to Present at Piper Sandler
Serán BioScience is excited to share that President & CEO, Dan Smithey, PhD, will present at the Piper Sandler 35th Annual Healthcare Conference on Tuesday, November 28, at 3:30 p.m. ET in New York City.
Piper Sandler is one of the most renowned healthcare conferences globally, attended by 350 of the most highly regarded companies operating in the life sciences industry. The conference hosts institutional and private equity investors, life science, biotechnology, and other specialty pharmaceutical companies. Panel discussions and fireside chats with industry experts will address the most relevant issues affecting healthcare and provide insight into the most current industry topics.
About Serán
Serán BioScience, LLC, is a science-driven drug development partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, email us at hello@seranbio.com.
Contact
Brinette Holdren
Director of Marketing
Serán BioScience, LLC
63047 Layton Ave,
Bend, OR 97701 USA
Phone: (541)-237-8501
www.seranbio.com
.svg)